Advanced search    

Search: authors:"Gregory Y. H. Lip"

42 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Heart Failure and Stroke

PurposeIschemic stroke significantly contributes to morbidity and mortality in heart failure (HF). The risk of stroke increases significantly, with coexisting atrial fibrillation (AF). An aggravating factor could be asymptomatic paroxysms of AF (so-called silent AF), and therefore, the risk stratification in these patients remains difficult. This review provides an overview of...

The relationship of early recurrence of atrial fibrillation and the 3-month integrity of the ablation lesion set

Early recurrence of atrial fibrillation (ERAF) after catheter-ablation (CA) can be a transient phenomenon due to inflammation, or a harbinger of late AF recurrence due to CA lesion (re)conduction. We studied the relationship between ERAF and the 3-month CA lesions integrity. Forty one consecutive AF patients who underwent a pulmonary vein isolation (PVI), roof line (RL) and...

Anticoagulation Resumption After Intracerebral Hemorrhage

, Beijing , China 1 Institute of Cardiovascular Sciences, University of Birmingham , Birmingham, England , UK 2 Gregory Y. H. Lip 3 Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg

Discontinuation risk comparison among ‘real-world’ newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban

and Outcomes Research, Bristol-Myers Squibb Company) for his editorial assistance in the preparation of this manuscript. Author Contributions Conceptualization: Gregory Y. H. Lip, Shital Kamble, Jack ... . Lip, Shital Kamble, Hemant Phatak. Writing ± review & editing: Gregory Y. H. Lip, Xianying Pan, Shital Kamble, Hugh Kawabata, Jack Mardekian, Cristina Masseria, Hemant Phatak. 10 / 11 1. Hansen ML

Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach

. Lip, Steve Deitelzweig. Formal analysis: Allison Keshishian, Melissa Hamilton, Ruslan Horblyuk, Kiran Gupta, Xuemei Luo, Jack Mardekian, Keith Friend, Anagha Nadkarni, Xianying Pan, Gregory Y. H. Lip ... , Jack Mardekian, Keith Friend, Anagha Nadkarni, Xianying Pan, Gregory Y. H. Lip, Steve Deitelzweig. 16 / 18 10. 11. 17 / 18 Lip GY, Keshishian A, Kamble S, Pan X, Mardekian J, Horblyuk R, et al. Real

Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study

Contributions Conceptualization: Gordon A. Begg, Gregory Y. H. Lip, Arun V. Holden, Sven Plein, Muzahir H. Tayebjee. Data curation: Gordon A. Begg, Rashed Karim, Tobias Oesterlein, Lee N. Graham, Andrew J ... . Hogarth, Stephen P. Page, Christopher B. Pepper, Arun V. Holden, Muzahir H. Tayebjee. Formal analysis: Gordon A. Begg, Tobias Oesterlein. Funding acquisition: Gregory Y. H. Lip, Sven Plein, Muzahir H

Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study

-Ryoung Lee, Kyung-Do Han, Myung-Jin Cha. Visualization: So-Ryoung Lee. Writing ± original draft: So-Ryoung Lee. Writing ± review & editing: Eue-Keun Choi, Seil Oh, Gregory Y. H. Lip. 12 / 14 16. Chao TF

The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey

Introduction Data on management of atrial fibrillation (AF) in the Balkan Region are scarce. To capture the patterns in AF management in contemporary clinical practice in the Balkan countries a prospective survey was conducted between December 2014 and February 2015, and we report results pertinent to the use of non-vitamin K antagonist oral anticoagulants (NOACs). Methods A 14...

Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review

Patients with atrial fibrillation (AF) are commonly managed with rhythm control strategy, but the natural history of this common arrhythmia leads itself to progression from paroxysmal to persistent or permanent AF, and recurrences are evident despite rhythm control treatments using cardioversion or catheter ablation. Numerous clinical factors have been associated with outcomes of...

Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation – A Nationwide Cohort Study

V105B-023). Author information Author notesTze-Fan Chao & Chia-Jen Liu These authors contributed equally to this work. Ta-Chuan Tuan & Gregory Y. H. Lip These authors jointly supervised this work ... journals • PubMed • Google ScholarSearch for Gregory Y. H. Lip in:Nature Research journals • PubMed • Google ScholarSearch for Shih-Ann Chen in:Nature Research journals • PubMed • Google Scholar

Prediction of very late arrhythmia recurrence after radiofrequency catheter ablation of atrial fibrillation: The MB-LATER clinical score

, SerbiaNebojša Mujović, Gregory Y. H. Lip & Tatjana S. PotparaUniversity of Birmingham Institute of Cardiovascular Science, City Hospital, Birmingham, United KingdomAlena Shantsila & Gregory Y. H. Lip ... Research journals • PubMed • Google ScholarSearch for Alena Shantsila in:Nature Research journals • PubMed • Google ScholarSearch for Gregory Y. H. Lip in:Nature Research journals • PubMed • Google

Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry

Background In patients with atrial fibrillation (AF), quality of oral anticoagulation control as well as impaired renal function are associated with adverse outcomes. Our objective was to analyze if there was a synergistic impact of these factors in determining adverse outcomes in AF patients undergoing percutaneous coronary intervention and stent (PCI-S). Methods Post-hoc...

Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor

Approximately 1 in 3–4 patients presenting with an ischemic stroke will also have atrial fibrillation (AF), and AF-related strokes can be effectively prevented using oral anticoagulant therapy (OAC), either with well-controlled vitamin K antagonists (VKAs) or non-vitamin K antagonist oral anticoagulants (NOACs). In addition, OAC use (both VKAs and NOACs) is associated with a 26...

Effects of Aspirin on Endothelial Function and Hypertension

Purpose of review Endothelial dysfunction is intimately related to the development of various cardiovascular diseases, including hypertension, and is often used as a target for pharmacological treatment. The scope of this review is to assess effects of aspirin on endothelial function and their clinical implication in arterial hypertension. Recent findings Emerging data indicate...

Determinants and Time Trends for Ischaemic and Haemorrhagic Stroke in a Large Chinese Population

Background The clinical epidemiology of stroke has been widely investigated in Caucasian populations, but the changes over time in the proportion of ischaemic to haemorrhagic strokes is less clear, especially in the Chinese population. Aims Our objective was to study the determinants and time trends for ischaemic and haemorrhagic stroke, in relation to age, in a large Chinese...

Relationship between renal function and circulating microparticles, soluble P-selectin and E-selectin levels in atrial fibrillation

Atrial fibrillation (AF) and chronic kidney disease are closely related, and any associated risk of stroke and thromboembolism due to AF is increased by concurrent renal dysfunction. The mechanism(s) for this include abnormalities in platelets and endothelial cells. We hypothesized relationships between levels of circulating platelet microparticles (PMPs, defined by CD42b...

Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation

Non-vitamin K antagonist oral anticoagulants (NOACs) are replacing warfarin and heparins in several clinical situations. With varying modes of action, the effects of NOACs on thrombus formation, integrity, and lysis is unknown. To determine whether two techniques of thrombelastography (TEG) and a micro-plate assay (MPA) provide novel data on thrombus formation, integrity and...

Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011–2015 in Denmark

journals • PubMed • Google ScholarSearch for Gregory Y. H. Lip in:Nature Research journals • PubMed • Google ScholarSearch for Christian Torp-Pedersen in:Nature Research journals • PubMed • Google

Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation

Hasegawa in:Nature Research journals • PubMed • Google ScholarSearch for Mitsuru Abe in:Nature Research journals • PubMed • Google ScholarSearch for Gregory Y. H. Lip in:Nature Research journals • PubMed

Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes

ScholarSearch for Gregory Y. H. Lip in:Nature Research journals • PubMed • Google Scholar Contributions G.B. conception and design, interpretation of data, writing of the manuscript. C.L. analysis and